Literature DB >> 3967133

Fibronectin, complement and immunoglobulins in serum after surgery.

T Gauperaa, K E Giercksky, A Revhaug, O P Rekvig.   

Abstract

In recent years it has been suggested that fibronectin is a non-specific opsonic protein of significance in host resistance against septic complications following trauma and surgery. The aim of the present study was to investigate the fluctuations in serum levels of fibronectin, immunoglobulins IgG and IgM, and complement factors C3 and C4 postoperatively. Serum samples were obtained pre-operatively and at different intervals postoperatively in 72 patients admitted for elective surgical procedures on the alimentary tract, the heart and the hip joint. The mean pre-operative fibronectin values were 257 +/- 79 micrograms/ml. The lowest values (166 +/- 65 micrograms/ml) were found immediately after the operation, followed by an increase which did not reach pre-operative levels within 120 h. Five patients who developed postoperative complications and 14 patients with malignant disease did not differ significantly either in their pre- or postoperative fibronectin levels, compared with the whole group. The lowest fibronectin levels seen were also significantly above the concentrations necessary to promote binding of gelatinized test particles to macrophages and monocytes in vitro. There was a significant decrease in C3, C4 and IgG levels postoperatively whereas IgM levels were unaltered. The observed reduction did not extend below the lower normal levels for these proteins. The probable mechanism behind the reduction in serum levels seems to be a sequestration at the site of tissue injury. The postoperative reduction in circulating fibronectin levels has probably no implications for host resistance against septic complications. When sequestered into the site of injury, it may, however, be of significance for normal wound healing, due to its cell-matrix interactions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3967133     DOI: 10.1002/bjs.1800720123

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  4 in total

1.  Plasma fibronectin and complement following infusion of colloidal solutions after spinal anaesthesia.

Authors:  J M Vedrinne; J P Hoen; D Bussery; C Veyssere; M Richard; J Motin
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

2.  Plasma fibronectin in Crohn's disease.

Authors:  A Allan; J Wyke; R N Allan; P Morel; M Robinson; D L Scott; J Alexander-Williams
Journal:  Gut       Date:  1989-05       Impact factor: 23.059

Review 3.  Fibronectin and the critically ill patient: current status.

Authors:  T M Saba; J L Kiener; J M Holman
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

Review 4.  A Novel Sex-Dependent Target for the Treatment of Postoperative Pain: The NLRP3 Inflammasome.

Authors:  Ashley M Cowie; Bonnie N Dittel; Cheryl L Stucky
Journal:  Front Neurol       Date:  2019-06-12       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.